Stanley Nkemjika | Medicine and Dentistry| Best Researcher Award

Posted on by ScienceFather

Dr. Stanley Nkemjika | Medicine and Dentistry| Best Researcher Award

Thomas Jefferson University, United States

He has held a variety of roles in the medical and academic fields over the years. From 2023 to 2024, he served as a Psychiatry Attending at both St. Joseph Medical Center, Yonkers, NY, and the Psychiatry ER Department of Psychiatry and Behavioral Sciences at Interfaith Medical Center, Brooklyn, NY. Additionally, he was the Chief Resident in the Department of Psychiatry and Behavioral Sciences at Interfaith Medical Center, One Brooklyn Health System, Brooklyn, NY. He has been a Psychiatry Resident at the same department since 2020. Prior to this, he worked as a Graduate Research Assistant at Georgia State University’s Department of Population Health (2019-2020) and at Georgia Southern University’s Department of Epidemiology (2018-2019). He also served as a Course Instructor at the Graduate School of Biomedical Sciences, Robert Wood Johnson Medical School, Rutgers University, from 2015 to 2018, and as a Research Associate at University Behavioral Health Care, Rutgers University, from 2013 to 2015. Earlier in his career, he worked as a Primary Care Physician in Nigeria, first at the Department of State Services Medical Center, Office of the Presidency (2010-2013), and then at the Department of Family Medicine, National Hospital, Office of the Presidency (2008-2010). He began his medical career as a Medical Intern at the University College Hospital in Ibadan in 2007-2008.

Professional Profile

Education

He has an extensive educational background in medicine and public health. He completed his Psychiatry Residency at the Department of Psychiatry and Behavioral Sciences, Interfaith Medical Center, One Brooklyn Health System, Brooklyn, NY, from 2020 to 2024. Before that, he was a Post-Doctoral Research Fellow in Global Mental Health at the Office of Global Health, Robert Wood Johnson Medical School, Rutgers University, from 2015 to 2018. In 2015, he earned a Master of Public Health (MPH) degree from the Department of Epidemiology, School of Public Health, Rutgers University. He obtained his Medical Doctor (MD) degree in 2007 from the College of Medicine, University of Ibadan.

Professional Experience

He has held several teaching positions in academia over the years. From 2019 to 2021, he was a Course Instructor for PH8721 Chronic Disease Epidemiology in the Department of Population Health, School of Public Health, Georgia State University, Atlanta, GA. In 2019, he also served as a Teaching Assistant for Research Methods II at the same institution. Prior to this, from 2014 to 2018, he was the Course Director for MSBS 5080S Primer on Global Health at the Graduate School of Biomedical Sciences, Robert Wood Johnson Medical School, New Brunswick, NJ.

 

Award and Honor

He has received several academic honors and awards throughout his career. In 2023, he was awarded second prize recognition for excellence in research by the Brooklyn Psychiatry Society. The previous year, in 2022, he earned the Underrepresented Minority Research Scholarship from the American Association of Addiction Psychiatry. In 2019, he was named a Second Century Initiative Research Fellow at Georgia State University. In 2015, he received the Community Service Award from the School of Public Health, Rutgers University. Earlier in his career, he was honored with the Postgraduate Scholarship Award from the Niger Delta Development Commission, Ministry of Niger Delta Affairs, Nigeria, in 2012. Additionally, in 2007, he was presented with the Academic Excellence and Leadership Award by the Ibadan College of Medicine Alumni Association at the College of Medicine, University of Ibadan.

 

Publications Top Noted
  • Brown C, Nkemjika S, Yankey B, Okosun I. Alternative Tobacco Product Use and Smoking Quit Attempts Among Teenagers in the United States: A Cross-Sectional Study. Cureus. 2021 Jul 29;13(7):e16740. doi: 10.7759/cureus.16740. PMID: 34471583; PMCID: PMC8403058.Pub Status: Published.
  • Atolagbe A, Nkemjika S, Popoola O, Oladeji O, Kogan I, Saeed H, Olupona T. Risperidone-Induced Neutropenia in a Schizophrenic Patient: A Case Report and Literature Review. Case Rep Psychiatry. 2021 Aug 17;2021:3980872. doi: 10.1155/2021/3980872. PMID: 34447597; PMCID: PMC8384506.Pub Status: Published.
  • Nkemjika S, Tokede O, Jadotte Y, Olatunji E, Bosah J, Pigott T, Okosun IS. Biological sex disparity in survival outcomes following treatment for renal cell carcinoma: a systematic review protocol. JBI Evid Synth. 2021 Jul 13. doi: 10.11124/JBIES-20-00277. Epub ahead of print. PMID: 34261092., Pub Status: Published.
  • Okosun IS, Nkemjika S, Okosun B, Lyn R, Airhihenbuwa CO. Lifestyle Modification Practices and Drug Prescription Use in Elderly Americans with Metabolic Syndrome: A Nationwide Population-Based Study [published online ahead of print, 2020 Jul 5]. J Natl Med Assoc. 2020;S0027-9684(20)30127-9. doi:10.1016/j.jnma.2020.06.008, Pub Status: Published.
  • Twum F, Morte N, Wei Y, Nkemjika S, Liu F, Zhang J. Red blood cell folate and cardiovascular deaths among hypertensive adults, an 18-year follow-up of a national cohort [published online ahead of print, 2020 Jun 11]. Hypertens Res. 2020;10.1038/s41440-020-0482-5. doi:10.1038/s41440-020-0482-5, Pub Status: Published.
  • Nkemjika S, Ifebi E, Cowan LT, et al. Association between serum folate and cardiovascular deaths among adults with hypertension. Eur J Clin Nutr. 2020;74(6):970-978. doi:10.1038/s41430-019-0533-7, Pub Status: Published.
  • Nkemjika, S.O., &Demissie, K. Breast feeding initiation time and its impact on diarrheal disease and pneumonia in West Africa. Journal of Public Health and Epidemiology. 2015, Dec; 7(2141- 2316): 352- 359. Cited in PubMed; PMID: JPHE., Pub Status: Published.
  • Nkemjika, S.O., &Taherisefat, M., & West, B., &Tokede, O.. Impact of violence on child growth and youth development: Newark, New Jersey study. International Journal of Current Research. 2016, Apr; 8(0975- 833X): 29695- 29700. Cited in PubMed; PMID: IJCR., Pub Status: Published.
  • Owolabi, W., &Davidow, A., & Thomas, P., & Mangala, R., &Nkemjika, S., &Tokede, O.. Relationship between ambient Air pollution (pm 2.5) and low birth weight deliveries in New Jersey. International Journal of Current Research. 2016, Jun; 8(0975- 833X): 33372- 33378. Cited in PubMed; PMID: IJCR, Pub Status: Published.

Junjie Liu | pharmaceutics | Best Researcher Award

Posted on by ScienceFather

Prof. Junjie Liu | pharmaceutics | Best Researcher Award

professor, Zhengzhou University, China

Liu Junjie is a professor and PhD supervisor at the School of Pharmacy, Zhengzhou University. 🎓 He completed his PhD in pharmaceutical sciences from Chongqing University in 2018. 📚 With over 40 publications in top journals like Sci Adv and Adv Mater, he is a recognized leader in his field. 🧬 He has led 10 major research projects, including grants from the National Natural Science Foundation of China. 🌍 Liu has received multiple prestigious honors, including youth talent support and high-level talent awards. 🚀 His contributions in pharmaceutical science are shaping the future of health and medicine.

Profile

Education🎓 

Liu Junjie obtained his PhD in pharmaceutical sciences from Chongqing University in 2018. 🏫 His advanced training in pharmaceutical sciences allowed him to develop expertise in drug development and pharmaceutical research. 📑 His education combined rigorous theoretical knowledge and hands-on experience in the laboratory, equipping him with the tools necessary for groundbreaking research. 🧪 He also pursued further professional development through leading postdoctoral research, continuously building on his PhD training. 💡 His academic foundation serves as the cornerstone for his innovative work in drug discovery and therapeutic development.

Experience🧑‍🏫 

Liu Junjie is currently a professor and PhD supervisor at Zhengzhou University’s School of Pharmacy. 🔬 He has extensive experience leading pharmaceutical research and managing collaborative research projects. 🧑‍🔬 Since completing his PhD, he has overseen 10 major research projects, including those supported by the National Natural Science Foundation of China. 🌟 His work has been featured in over 40 SCI-indexed publications as the first or corresponding author, showcasing his strong research output. 🌿 Liu is also actively involved in mentorship, guiding PhD students and shaping the next generation of pharmaceutical scientists.

Awards and Honors🏆

Liu Junjie has received numerous prestigious awards for his contributions to pharmaceutical research. 🎖️ Notably, he has been recognized by the China Association for Science and Technology with the Youth Talent Support award. 🌟 His high-level talent and innovative contributions to the field have earned him recognition in Henan Province, where he received the High-level Talent Award and was named an Outstanding Youth Talent in the Central Plains. 💼 Additionally, he was awarded the Innovative Talent Award for his role in advancing pharmaceutical research at Henan’s Higher Education Institutions.

Research Focus🔬 

Liu Junjie’s research focuses on the development of innovative drugs and therapeutic treatments. 🧪 His work aims to bridge the gap between basic pharmaceutical sciences and clinical applications, exploring drug delivery systems and novel therapeutic materials. 🧬 He is particularly interested in precision medicine and the design of targeted therapies to improve treatment efficacy and minimize side effects. 🌍 His interdisciplinary research integrates chemistry, biology, and materials science to advance drug development, leading to over 40 high-impact publications in renowned scientific journals. 📈 His research aims to transform healthcare and patient outcomes.

Publication Top Notes

In situ implantable DNA hydrogel for diagnosis and therapy of postoperative rehemorrhage following intracerebral hemorrhage surgery

Published in: Science Advances (2024, 10(33), ado3919)
Authors: Yu, W., Gong, E., Wang, C., Liu, J., Shi, J.
Overview: This research focuses on a DNA hydrogel that can be implanted in situ to diagnose and treat rehemorrhage after intracerebral hemorrhage surgery, providing a new tool for post-surgical care.

2. In situ formation of biohybrid system based on Streptococcus pneumoniae for enhanced radical therapy against tumors

Published in: Cell Reports Physical Science (2024, 5(7), 102074)
Authors: Zhao, X., Wang, Q., Dong, H., Liu, J., Shi, J.
Overview: The study explores a biohybrid system using Streptococcus pneumoniae for improved radical cancer therapies, targeting tumors more effectively.

3. Retraction Note: Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade

Published in: Journal of Nanobiotechnology (2024, 22(1), pp. 302)
Authors: Wang, S., Yin, N., Li, Y., Si, P., Liu, J.
Overview: This article was retracted, but it originally examined how copper-based frameworks prevent breast cancer metastasis by blocking estrogen and platelets.

4. A Neutrophil Hijacking Nanoplatform Reprograming NETosis for Targeted Microglia Polarizing Mediated Ischemic Stroke Treatment

Published in: Advanced Science (2024, 11(17), 2305877)
Authors: Yin, N., Wang, W., Pei, F., Wang, Z.-H., Liu, J.
Overview: The research proposes a nanoplatform that hijacks neutrophils to treat ischemic stroke by modulating microglia polarization.

5. Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence

Published in: Advanced Materials (2024, 36(14), 2307923)
Authors: Geng, S., Guo, P., Wang, J., Shi, J., Liu, J.
Overview: This article focuses on an optical sensor integrated with a hydrogel to detect and remove microtumors post-surgery, reducing cancer recurrence risk.

6. Biomimetic Nanovehicle-Enabled Targeted Depletion of Intratumoral Fusobacterium nucleatum Synergizes with PD-L1 Blockade against Breast Cancer

Published in: ACS Nano (2024, 18(12), pp. 8971–8987)
Authors: Geng, S., Guo, P., Li, X., Liu, J., Yang, Y.
Overview: This study examines a nanovehicle that targets Fusobacterium nucleatum within tumors to boost the effectiveness of PD-L1 blockade therapies for breast cancer.

Conclusion

Liu Junjie is an excellent candidate for the Best Researcher Award. His robust academic output, leadership in research projects, mentorship, and numerous recognitions make him well-suited for this prestigious recognition. While expanding his international collaborations and increasing the practical application of his research could further enhance his candidacy, his contributions to pharmaceutical sciences and his leadership in innovative research projects make him a strong contender for this award.